FirstHealth ending mass vaccination clinic as demand dwindles

WASHINGTON (AP) — The U.S. is recommending a “pause” in using the single-dose Johnson & Johnson COVID-19 vaccine to investigate reports of potentially dangerous blood clots. The Centers for Disease Control and Prevention and the Food and Drug Administration said Tuesday they were investigating clots in six women in the days after vaccination, in combination with reduced platelet counts.

More than 6.8 million doses of the J&J vaccine have been given in the U.S., the vast majority with no or mild side effects. A CDC committee will meet Wednesday to discuss the cases and the FDA has also launched an investigation.

The North Carolina Department of Health and Human Services has released the following statement regarding the CDC and FDA’s joint statement on Johnson & Johnson COVID-19 vaccine:

“Our primary concern is the health and safety of all North Carolinians. Out of an abundance of caution, we are following the recommendations of the FDA and CDC and have paused the administration of the Johnson & Johnson COVID-19 vaccine until we learn more. The safety system in place is working as it should. If you have an appointment for Pfizer or Moderna, please go to your appointment as planned. If you have an appointment for Johnson & Johnson, your appointment will be rescheduled.”

This article was written with the help of The Associated Press.

Copyright 2021, The Associated Press. All rights reserved.

 

Photo courtesy of FirstHealth of vaccine clinic at the Fairbarn in Pinehurst.

Print Friendly, PDF & Email